SAN FRANCISCO, CA -- (MARKET WIRE) -- May 23, 2007 -- Asthmatx, Inc., a medical device company that has developed a catheter-based procedure for the treatment of asthma, announced today that positive results from the Research in Severe Asthma (RISA) Trial were reported today at the annual scientific assembly of the American Thoracic Society (ATS) by Neil Thomson, MD, Professor of Respiratory Medicine, University of Glasgow, Glasgow, Scotland. Clinically and statistically significant improvements in pulmonary function, asthma control, and quality of life, as well as a reduction in use of rescue medications, were observed following the bronchial thermoplasty procedure in patients with severe asthma. Bronchial Thermoplasty is an innovative non-drug treatment for asthma under clinical investigation in the United States.
